Eurand Inc.

David Poliachik
845 Center Drive
Vandalia, OH 45377
Phone: 937-898-9669
Email: david.poliachik@eurand.com
Website: www.eurand.com/

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had five products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners.

Eurand has a strong track record of developing products using its innovative drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has four primary technology platforms:

* Customized Drug Release
* Bioavailability Enhancement
* Taste Masking / Orally Disintegrating Tablets (ODTs)
* Drug Conjugation

These platforms include nine distinct technologies and are covered by more than 300 patents. Eurand uses these technologies to develop and expand the Company's own internal pipeline and to partner with pharmaceutical and biopharmaceutical companies to develop their products.

Currently more than 40 products using these technologies are commercialized worldwide in a range of therapeutic indications.

Technology: Biomedical Sciences - Manufacturing
Adv. Mfg. Sector: Pharmaceuticals

What Do We Make?
Eurand has had five products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners.

Eurand is a leading industry partner that provides the broadest range of novel and proven oral drug delivery technologies. Using these technologies, we turn difficult drug candidates into easy to administer, successful pharmaceutical products. Additionally, our technologies can be used to enable the creation of new chemical entities and can also be used as innovative and effective life cycle management tools that can prolong the market life of products.

We have established partnerships with major pharmaceutical companies, including Abbott, Wyeth, Novartis, Bristol-Myers Squibb, Sanofi Aventis, GlaxoSmithKline, Roche and Bayer.

We have a number of Rx and OTC products available for licensing. In general, these products are new formulations of existing drugs that incorporate one or more of our proprietary drug delivery technologies. We license these products to pharmaceutical companies for marketing throughout the world.

How Do We Make It?
We manufacture all of the products that we develop for ourselves and our licensees. Our manufacturing processes and units are integrated with our R&D facilities thereby facilitating the scale-up and manufacturing process for products in development. Shared facilities, processes and development teams enhance this strategy. Additionally, we have facilities in the U.S. and in Italy approved to process controlled substances. Our manufacturing sites are regularly inspected by national regulatory agencies and our licensees.

Facts About Our Company
Eurand has based one of its R&D centers of excellence in the Dayton, Ohio facility. Products are supplied from this facility to the North American, South American and European markets. In this facility, our processing technologies and capabilities include granulation, coacervation, fluid-bed processes, pan coating, blending, tableting (standard, minitablet, orally disintegrating tablets) encapsulation and organic-solvent processing capabilities.

Adv. Mfg. Jobs at Our Company
As a rapidly growing, specialty pharmaceutical company, it's our employees that make the Company's work distinctive and successful. In the Dayton, Ohio facility, the group comprises formulation, analytical, regulatory and clinical functions and is involved in the development of products for Eurand and our partners. Team member qualifications include advanced degrees in diverse fields: Chemical Engineering, Business (MBA), Bioengineering, Analytical Chemistry, Pharmaceutics and Industrial Pharmacy.